Sterneck Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-58,485
Closed -$350K 113
2026
Q1
$350K Hold
58,485
0.16% 79
2025
Q4
$419K Buy
58,485
+4,794
+9% +$37.9K 0.19% 67
2025
Q3
$573K Buy
53,691
+6,599
+14% +$64.8K 0.27% 49
2025
Q2
$456K Buy
+47,092
New +$486K 0.23% 58

Other funds holding OGN

Sterneck Capital Management's OGN Position: Q2 2026 in Review

Sterneck Capital Management sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 58,485 shares — an estimated $350K sold.

Sterneck Capital Management first reported a position in OGN in Q2 2025 and held it in 4 quarters. The position peaked at $573K in Q3 2025. 634 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Sterneck Capital Management reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • Sterneck Capital Management sold 58,485 Organon & Co shares in Q2 2026, an estimated $350K.
  • Sterneck Capital Management first reported a position in Organon & Co in Q2 2025 and held it in 4 quarters.
  • Sterneck Capital Management's Organon & Co position peaked at $573K in Q3 2025.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Sterneck Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.